Measurement of Efferent Neural Drive From Respiratory Centers to Upper Airways Using Electromyography (EMG) of Genioglossus (GG) in Patients Dependent on Invasive Mechanical Ventilation
1 other identifier
interventional
10
1 country
1
Brief Summary
Muscle activity in the upper airway is influenced by specific states such as anesthesia, sleep, wakefulness, and the phases of respiration. The hypoglossal nerve, which innervates the genioglossus muscle, receives input from the brain's sleep-wake center, respiratory pattern-generating neurons, chemoreceptors, and airway negative pressure receptors. Preliminary activation of the genioglossus muscle and other upper airway dilators by the hypoglossal nerve occurs approximately 50-200 ms before innervation of the phrenic motor neurons and the subsequent action of the diaphragm. The forward movement of the genioglossus increases the stiffness and diameter of the upper airway, effectively counteracting collapse forces during inspiration. Assessing genioglossus function could prove critical in determining the optimal timing for extubation. This requires a methodology to evaluate the upper airway by measuring genioglossus activity in intubated patients. In the future, this could provide an objective measure for assessing suitability for extubation. This study explores a method for measuring the electrical activity of the upper airway muscles and the diaphragm in ventilated patients and correlates the results in a systematic view.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 9, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
September 25, 2026
September 1, 2026
6 months
September 9, 2026
September 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion (with 95% confidence intervals) of participants meeting the stimulation success criterion.
Proportion (with 95% confidence intervals) of participants meeting the stimulation success criterion.
6 months
Secondary Outcomes (4)
Proportion completing each measurement (Baseline - initial, Challenge, Baseline - subsequent).
6 months
Change in GG-EMG amplitude from baseline to physiological challenge quantified as RMS or peak-to-peak
between Day 1 and Day 3 recordings
Change in GG-EMG amplitude between Day 1 and Day 3 recordings
1-3 days
Correlation of EMG metrics and clinical variables (e.g., sedation depth, PCO₂, neurological status)
6 months
Study Arms (1)
patients dependent on invasive mechanical ventilation and extubation
EXPERIMENTALInterventions
Measurement of efferent neural drive from respiratory centers to upper airways using electromyography (EMG) of genioglossus (GG) in patients dependent on invasive mechanical ventilation
Eligibility Criteria
You may qualify if:
- Age 18 years or older.
- Dependent on invasive mechanical ventilation in ICU
- Awakening patient: improving neurological status (+2 points on the GCS compared to admission)
- Patient weaning from mechanical ventilation: presence of ventilator-recorded weaning trigger.
You may not qualify if:
- Known pregnancy
- Unstable intracranial pressure
- Pacemaker, internal defibrillator or pacing device wearers.
- Aneurysms at risk of rupture
- Severely impaired gas exchange despite optimal therapy
- GCS \< 5 or clinical signs of poor prognosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardy, 27100, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 9, 2026
First Posted
September 25, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
September 25, 2026
Record last verified: 2026-09